Adjuvant Systemic Anti-cancer Therapy in Early Breast Cancer During the COVID-19 Pandemic: Differences between Clinicians and Patients in Perception of Treatment Risks and Benefits

Detalles Bibliográficos
Autores principales: Gatfield, E.R., Mukesh, M.B., Loo, S.W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal College of Radiologists. Published by Elsevier Ltd. 2020
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280104/
https://www.ncbi.nlm.nih.gov/pubmed/32536560
http://dx.doi.org/10.1016/j.clon.2020.06.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280104/
https://www.ncbi.nlm.nih.gov/pubmed/32536560
http://dx.doi.org/10.1016/j.clon.2020.06.001

Ejemplares similares